uz
Feedback
๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ

Kanalga Telegramโ€™da oโ€˜tish

ุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2bot

Ko'proq ko'rsatish

๐Ÿ“ˆ Telegram kanali ๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ analitikasi

๐—”๐—ฅ๐—ข๐—ก ๐—ฆ๐—ง๐—จ๐——๐—ฌ (@aronstudy) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 13 355 obunachidan iborat bo'lib, Tibbiyot toifasida 1 923-o'rinni va Saudiya Arabistoni mintaqasida 5 681-o'rinni egallagan.

๐Ÿ“Š Auditoriya koโ€˜rsatkichlari va dinamika

ะฝะตะฒั–ะดะพะผะพ sanasidan buyon loyiha tez oโ€˜sib, 13 355 obunachiga ega boโ€˜ldi.

27 Iyun, 2026 dagi oxirgi maโ€™lumotlarga koโ€˜ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 213 ga, soโ€˜nggi 24 soatda esa -17 ga oโ€˜zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya oโ€˜rtacha 27.63% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 9.86% ini tashkil etuvchi reaksiyalarni toโ€˜playdi.
  • Post qamrovi: Har bir post oโ€˜rtacha 3 695 marta koโ€˜riladi; birinchi sutkada odatda 1 318 ta koโ€˜rish yigโ€˜iladi.
  • Reaksiyalar va oโ€˜zaro taโ€™sir: Auditoriya faol: har bir postga oโ€˜rtacha 36 ta reaksiya keladi.
  • Tematik yoโ€˜nalishlar: Kontent ู…ูŽุงุฏูŽู‘ุฉ, ุทูŽุงู„ูุจ, ุงูุณุชูุจููŠูŽุงู†, ุณูŽู„ูŽุงู…, ุฑูุณูŽุงู„ูŽุฉ kabi asosiy mavzularga jamlangan.

๐Ÿ“ Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida taโ€™riflaydi:
โ€œุจุณู… ุงู„ู„ู‡ ุงู„ุฑุญู…ู† ุงู„ุฑุญูŠู… ุงู„ู„ู‡ู… ุตู„ ุนู„ู‰ ู…ุญู…ุฏ ูˆุขู„ ู…ุญู…ุฏ ู…ุญุชูˆู‰ ุงู„ู‚ู†ุงุฉ: ุดุฑูˆุญุงุช ุตูŠุฏู„ุฉ ุนุถูˆูŠุฉ ู…ุฑุญู„ุฉ ุซุงู†ูŠุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุซุงู„ุซุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุงูˆู„ ูุงุฑู…ุง ู…ุฑุญู„ุฉ ุฑุงุจุนุฉ ูƒูˆุฑุณ ุซุงู†ูŠ ุนู„ุงุฌูŠุงุช ู…ุฑุญู„ุฉ ุฎุงู…ุณุฉ ู„ู„ุชูˆุงุตู„: @AronX2botโ€

Yuqori yangilanish chastotasi (oxirgi maโ€™lumot 28 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli boโ€˜lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim taโ€™sir nuqtasiga aylantirishini koโ€˜rsatadi.

13 355
Obunachilar
-1724 soatlar
+3037 kunlar
+21330 kunlar
Postlar arxiv
A 28-year-old male with schizophrenia has failed two adequate trials of second generation antipsychotics He continues to experience persistent hallucinations and delusions. Which medication should be considered next according to treatment guidelines?
Anonymous voting

https://youtu.be/7SyTpEdhBLw?si=NiKbYDTt4EGjo8bo https://youtu.be/QORlwMeWOeU?si=rifLSltvF0ulKRXw ุงุฎูˆุงู† ู‡ุงูŠ ุจุนุถ ุงู„ุญุฑูƒุงุช ุงู„ูŠ ุงุณุชุนุฑุถุชู‡ุง ุงู„ูƒู… ุจุงู„ู…ุญุงุถุฑุฉ ุฎุงู ุชุญุชุงุฌูˆู†ู‡ุง

ุดุจุงุจ ู‡ุงูŠ ู…ู„ุฎุตุงุชูŠ ู„ู„ TDM ู‚ุจู„ ุณู†ุชูŠู† ู…ู…ูƒู† ุชููŠุฏูƒู…

#TDM ู…ุฌู…ูˆุนุฉ ู…ุณุงุฆู„ ู…ู† ุงู„ู…ุตุฏุฑ ุจู‚ูŠุฉ ุงู„ู†ู‚ุงุท ุชูƒุฏุฑูˆู† ุชุฑุฌุนูˆู† ุงู„ู‡ุง ุจุงู„ู…ุตุฏุฑ ู†ูุณ ุงู„ุชุทุจูŠู‚

ู‚ูˆุงู†ูŠู† pk parameters
+1
ู‚ูˆุงู†ูŠู† pk parameters

ู‚ูˆุงู†ูŠู† ุงู„ concentration
ู‚ูˆุงู†ูŠู† ุงู„ concentration

- ุงู„ุฑุณุงู„ู‡ ุ› https://docs.google.com/forms/d/e/1FAIpQLSdZ3--TMWMh57TI-rdPmXmC7AeWvTklvidjOu7pGpnnjaFgSw/viewform?usp=header ุงู„ุณู„ุงู… ุนู„ูŠูƒู… ู…ู…ูƒู† ู†ุดุฑ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ู†ุฑุฌูˆ ู…ู† ุญุถุฑุงุชูƒู… ุงู„ุชูุถู„ ุจุงู„ู…ุดุงุฑูƒุฉ ููŠ ู‡ุฐุง ุงู„ุงุณุชุจูŠุงู† ุงู„ุนู„ู…ูŠ ุงู„ุฎุงุต ุจุจุญุซ ุงู„ุชุฎุฑุฌ ุงู„ุฎุงุต ุจุทู„ุจุฉ ุงู„ู…ุฑุญู„ุฉ ุงู„ุฎุงู…ุณุฉ ูƒู„ูŠุฉ ุงู„ุตูŠุฏู„ุฉ ุญูˆู„ ุงุณุชุฎุฏุงู… ุงู„ู…ุถุงุฏุงุช ุงู„ุญูŠูˆูŠุฉ ู„ุนู„ุงุฌ ู†ุฒู„ุงุช ุงู„ุจุฑุฏ ูˆุงู„ูู„ุงูˆู†ุฒุง. ุงู„ุงุณุชุจูŠุงู† ู„ู† ูŠุณุชุบุฑู‚ ุฃูƒุซุฑ ู…ู† ุฏู‚ูŠู‚ุชูŠู†. ุดุงูƒุฑูŠู† ุชุนุงูˆู†ูƒู…

Adverse effects of chemotherapy.pdf1.98 MB